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Abstract 
Uncontrolled diabetes is a known risk factor for increasing the incidence of postoperative 
complications and one of the many challenges that providers often face when doing pre-
operative evaluations on patients with diabetes.  We will look at a specific case study that 
describes a patient who presented for a preoperative evaluation for an elective right knee 
arthroplasty, who has type 2 diabetes mellitus, and compare the case study against the literature 
review analysis to determine if this patient should be cleared for surgery.  A literature review was 
conducted using CINAHL complete and was found to have current literature regarding 
preoperative glycated hemoglobin for review. Upon analysis of the literature review studies, no 
definite consensus was appreciated regarding an ideal preoperative glycated hemoglobin value to 
reduce the risk of postoperative complications. Resources were lacking when taking additional 
factors into account, such as comorbidities and distinguishing between type 1 and type 2 diabetes 
variables. The question of an ideal preoperative glycated hemoglobin is a crucial one to address, 
for without a definitive answer the healthcare system is putting patients at risk of preventable 
postoperative complications and unnecessary hospital stays. 
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Is there an ideal pre-operative glycated hemoglobin for a patient with type 2 diabetes mellitus for 
prevention of post-operative complications? 
Background 
 It is well known and widely agreed that people who have diabetes have a greater risk of 
post-operative surgical site infections, especially when they have elevated glycated hemoglobin 
(HbA1c) levels (Nicolini et al.,2018). An elevated glycated hemoglobin correlates with 
uncontrolled diabetes. However, there does not seem to be a consensus on what constitutes an 
elevated glycated hemoglobin in the literature reviewed. 
 The purpose of this paper is to use evidence-based research to evaluate what an ideal 
glycated hemoglobin should be preoperative to help decrease the risk of postoperative 
complications. While there may be a strong consensus that elevated blood sugars contribute to 
postoperative complications, there does not seem to be a consensus on an ideal preoperative 
glycated hemoglobin for a clinician who is performing a preoperative evaluation. Next, we will 
review a case study that will guide us in our literature review. 
Case Report 
Name: T. Smith 
Age; 46 
Date of Visit: March  
Examiner:  Tammy Branden, FNP student at UND 
Gender:  Female 
Race: Caucasian 
Language: English 
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Historian:  Patient, who is an excellent historian 
Chief Complaint: 
Preoperative evaluation for a right knee arthroplasty. 
History of Present Illness: 
A 46-year-old female presented to the clinic today for a preoperative evaluation for a right knee 
arthroplasty. She is scheduled to have surgery in 2 weeks with Dr. Knee. Patient reports that she 
suffered a meniscal tear in her right knee approximately 6 months ago when she fell on ice and 
her right knee slid under her. She is controlling her pain by taking Ibuprofen 600 mg TID and 
alternating with Tylenol 1000 mg TID. She is checking fasting blood sugars daily with stated 
results of “90-100.” Denies any previous issues with anesthesia or any family members with 
malignant hyperthermia. Denies any recent URI symptoms. No known bleeding disorders. Does 
smoke one pack cigarettes per day. 
Current Medications: 
Lisinopril -10 mg daily 
Metformin- 1000 mg BID 
Rybelsus- 7 mg daily 
Synthroid- 125 mcg daily 
Aspirin – 81 mg daily 
Tylenol – 1000 mg TID (pain related to right knee) 
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 Past Medical History: 
Hypertension 
Obesity 
Type 2 Diabetes (Diagnosed 3 years ago) 
Hypothyroidism (Diagnosed one year ago) 
Squamous Cell Skin Carcinoma (Right forearm) 
Past Surgical History: 
Hysterectomy (44 years old) 
Skin biopsy (Right forearm, 2 years ago) 
C Section x 2 (10/15 years ago) 
Family History: 
Father (Alive) CAD with stenting x3 @ age 55, prostate cancer, hypertension, hyperlipidemia 
Mother (Alive) Breast cancer @ age 60, hypertension, obesity 
Maternal Grandmother (Alive) Hypertension, breast cancer. 
Maternal Grandfather (Alive) No known medical/mental health issues 
Paternal Grandfather (Alive) hypertension, melanoma 
Paternal Grandmother (Deceased) CVA @ age 80 
Sister (Alive,33y/o) No known medical/mental health issues 
Brother (Alive, 28y/o) No known medical/mental health issues 
 Social History: 
Married 
2 children (10 & 15) 
Tobacco: 1ppd x 20 years 
Alcohol: Rare 
Illicit drug use: None 
Works full-time as an administrative assistant 
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Review of Systems: 
Constitutional: Denies any fevers, chills, no weight loss, no activity change 
HEENT: Denies any ear pain/drainage or sore throat, sinus pressure or drainage, denies any 
lymph soreness/enlargement 
Cardiovascular: Denies any chest pain, SOB, can walk a block without SOB, denies leg 
swelling 
Pulmonary/Chest: Denies any cough, wheezing 
Gastrointestinal: Denies any nausea, vomiting, diarrhea, or constipation 
Genitourinary: No dysuria, or frequency 
Musculoskeletal: Right knee pain 
Hematologic: Denies any bleeding issues regarding herself or her family 
Skin: Denies any rashes, sores 
Physical Examination: 
Vital signs: BP: 136/88, Pulse: 78, R: 12 / Temp: 98.5F (oral) SPo2: 95% on RA 
Height: 5’6”, Weight: 211 lbs (95.9 kg) BMI: 34 
Constitutional: She is orientated to person, place, and time. Appears well-developed and well-
nourished. No acute distress. 
HEENT: 
Right ear: Tympanic membrane and external ear normal. 
Left ear: Tympanic membrane and external ear normal. 
Nose: No sinus tenderness. No sinus drainage.  
Moth/Throat: Oropharynx is clear and moist. She does not have any dentures or missing teeth. 
No oropharyngeal exudate. 
Neck: Normal range of motion.  
Cardiovascular: Regular rate and rhythm. Normal heart sounds, no murmurs heard. 
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Pulmonary/Chest:  Effort normal and breath sounds normal. No respiratory distress, or 
wheezes.  
Abdominal: Soft. Bowel sounds in all 4 quadrants. No distention or tenderness on palpation. 
Musculoskeletal: No edema. Right knee pain on palpation. 
Lymphadenopathy: No cervical adenopathy. 
Neurological: Alert and orientated to person, place, and time. 
Skin: Skin is warm. No sores or rashes noted. 
Psychiatric: Normal mood and affect. 
Screening needed pre-operatively: 
CBC, CMP, HgbA1c, TSH, EKG 
Results: 
Hemoglobin, Platelets, Electrolytes are all WNL. TSH is WNL. HgbA1c is 6.2%. EKG is NSR. 
Patient is fit to go ahead with surgery as of today’s exam and lab work.  
Instructions: 
Please let Dr. Knee know if you develop any temperature (> 100.5) or upper respiratory 
symptoms (cough, sinus issues, sore throat). 
Stop taking your aspirin 7 days before your surgery. 
Try and not smoke the day of your surgery. 
Do not take any medications the day of your surgery. You may take all your medications (except 
your aspirin) as normal until the day of your surgery. 
Risks of surgery and anesthesia including infection, bleeding, and death were reviewed with the 
patient. The patient was advised to notify her surgeon of any fevers or URI symptoms that come 
up between today and her surgery date. 
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Literature Review 
Search Strategies 
 A literature search was performed using the Cumulative Index to Nursing and Allied 
Health Literature (CINAHL) complete database.  Key words used in the search included a 
combination of terms including: (a) “diabetes”; (b) “surgery”; (c) “glycated hemoglobin”. The 
search was limited to the last 5 years, included only human subjects, peer-reviewed articles, and 
English text only.  These limitations were intended to ensure the literature was current, pertained 
to the nursing discipline, and could be applicable to this paper’s analysis and evaluation.   The 
search with (a) “surgery” and (b) “glycated hemoglobin” produced 142 articles. When the search 
was more detailed and included all three terms above “diabetes” AND “surgery” AND “glycated 
hemoglobin” it produced 73 articles with 12 being pertinent to the question presented.  
 No other searches were conducted beyond CINAHL complete, including reference 
sections or grey literature.  
Analysis of Literature 
 According to the Centers for Disease and Control Prevention (CDC), there are 34+ 
million Americans who currently live with diabetes and 88 million more who have pre-diabetes 
(CDC, 2020). This statistic is further broken down by the American Diabetes Association (ADA) 
which states the portion of these 34+ million Americans, who live with type 1 diabetes, is 1.6 
million (ADA, 2020). These are staggering numbers. The gold standard for assessing these 
individuals with diabetes is a glycated hemoglobin laboratory test (ADA, 2020). This test shows 
how well the blood glucose has been controlled for the past two-three months and is performed 
every three-six months (ADA, 2020). The glycated hemoglobin can be tested by either a finger 
stick in the clinic office or by lab venipuncture. The laboratory results are provided in a 
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percentage and the percentage correlates with an average blood glucose (ADA, 2020). For 
example, a 7.0% result would correlate with an average blood glucose of 154 mg/dl over the past 
two-three months (ADA, 2020). The glycated hemoglobin value increases as the average blood 
glucoses increase (ADA, 2020). The goal glycated hemoglobin for most adults is <7.0% (ADA, 
2020), but can be adjusted higher to accommodate for comorbidities, hypoglycemia 
unawareness, and safety.  
 While reviewing the preceding case, one can see that the patient has type 2 diabetes 
mellitus and is taking two different oral medications for it. She is undergoing an elective surgery, 
which raises the question of how her glycemic control preoperatively will affect her risk of 
postoperative complications. 
 Uncontrolled diabetes, “as measured by elevated HbA1c concentrations, has been 
associated with poor surgical outcomes for emergency and elective patients in many surgical 
specialties” (Dhatariya et al., 2016, p. 431). Breaking down the literature review articles by 
glycated hemoglobin results show that two studies cite a pre-operative HbA1c of > 6.5% should 
be obtained (Goodenough et al., 2015; Shohat et al., 2018); one study cites that a HbA1c of 6-7% 
should be obtained (Biancari & Giordano, 2019); two studies recommend a HbA1c of 7.0 % 
(Pinxia Chen et al., 2018; Rollins et al., 2016) while yet another states > 7.0% as a goal (Nicolini 
et al., 2018).  Another study states a HbA1c of 7.5% as acceptable (Cancienne, Cooper, et al., 
2017) while another gives > 8.0% as acceptable (Hwang et al., 2015).  Two studies state a 
preoperative HbA1c of 8.5% as reasonable (Dhatariya et al., 2016; Haines et al., 2018). One 
study did not give an actual glycated hemoglobin value and just stated that an elevated glycated 
hemoglobin contributes to surgical complications (Blankush et al., 2016) while another study 
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stated “increasing risk for superficial infection is found with increasing HbA1c levels” 
(Cancienne, Werner, et al., 2017, p. 1646) but also did not give a glycated hemoglobin value.  
 More research is needed to determine what an ideal preoperative glycated hemoglobin 
value should be.  A current consensus on an ideal preoperative glycated hemoglobin throughout 
these studies is lacking. This lack of consensus in the literature potentially puts patients with 
elevated glycated hemoglobin’s, undergoing elective procedures, at increased risks. The literature 
is lacking a specific guideline on when an elective surgery should be cancelled or postponed due 
to a glycated hemoglobin result.  One must always look at their institution guidelines, however 
there should be a definitive consensus between the experts on this matter as well.  
 The studies support a significant linkage between a higher glycated hemoglobin and 
increased risk of complications postoperatively (Biancari & Giordano, 2019; Blankush et al., 
2016; Cancienne, Cooper et al., 2017; Cancienne, Werner, et al., 2017; Dhatariya et al., 2016; 
Goodenough et al., 2015; Haines et al., 2018; Hwang et al., 2015; Nicolini et al., 2018; Rollins et 
al., 2016; Pinxia Chen et al., 2018; Shohat et al., 2018), although they do not agree on what 
constitutes an “elevated” glycated hemoglobin. Some of the postoperative complications that 
commonly occur with an elevated HgbA1c include surgical site infection, systemic infections, 
urinary tract infections, lower respiratory tract infections, acute kidney injury, acute coronary 
syndrome, pneumonia, intensive care admission, prolonged stay in hospital, and even death 
(Dhatariya et al., 2016). 
 One study that specifically looked at total knee arthroplasty in patients who have diabetes 
found: 
 Patient HbA1c levels were not reliable predictors of the risk of infection after total joint 
 arthroplasty. Furthermore, the conventional cutoff HbA1c level of less than or equal to 7 
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 was reported to have poor predictive value for the development of postoperative wound 
 complications and prosthetic joint infection (Hwang et al., 2015, p. 1727). 
 This contrasted with another study focusing on total knee arthroplasty (TKA) and 
diabetes which found that a glycated hemoglobin level “greater than 8.0 mg/dL might serve as a 
threshold for an increased risk of deep postoperative infection after TKA (Cancienne, Werner et 
al., 2017, p.1727). Cancienne, Werner et al., (2017) also felt that the glycated hemoglobin was 
not adequate as an indicator of postoperative complications in and of itself.  
 Recent data that solely studied total knee arthroplasty recipients, who also had diabetes, 
found that there was a strong correlation between both joint and systemic complications in 
addition to an increase in the cost of care (Shohat et al., 2018).This same study stated that a 
patient should have a glycated hemoglobin of 6.5% pre-operatively and that they will cancel 
surgery if the pre-operative glycated hemoglobin is greater than 8.0% (Shohat et al., 2018). The 
American Diabetes Association takes the stand that surgery should not “be undertaken at all 
possible if the HbA1c exceeds 7%” (Rollins et al., 2016, p. 308).  
  Conversely, another study only analyzed the glycated hemoglobin without relation to a 
specific surgery, noted that there was a significant correlation between preoperative glycated 
hemoglobin and postoperative complications and stated that those who had a HgbA1c of 6.5% 
developed less complications than those who had a HgbA1c of 7.9% (Pinxia Chen et al., 2018). 
This is a difference between having an average blood sugar of 140 mg/dl versus 180 mg/dl 
respectively.  
 Blankush et al., (2016) found that in non-cardiac surgeries, if a preoperative glycated 
hemoglobin was less than 7%, chances of postoperative complications were greatly reduced. 
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 Another broader study that did not identify a specific surgical population procedure, but 
studied only non-emergency surgeries in 2200 individuals, found a strong correlation between 
having sustained elevated blood sugars and an impaired immune system which could easily lead 
to postoperative complications (Blankush et al., 2016). The study also concluded that people 
with diabetes, no matter the preoperative level of glycated hemoglobin, generally did not do as 
well as those who did not have any diagnosis of diabetes (Blankush et al., 2016). 
 While the studies do concur that good glucose control prior to surgery is important, the 
studies also lack information in vital areas. There was no mention of comorbidities as something 
that could also put an individual with diabetes at an increased risk of postoperative complications 
or if a lower preoperative glycated hemoglobin would be indicated for such individuals versus 
someone with no comorbidities. Studies addressing this issue are becoming increasingly 
important as large numbers of people are living longer with diabetes, in congruence with other 
chronic health issues, and require preoperative clearance as well.  
 Another area where studies lack is in children and adults with type 1 diabetes. Most 
studies included participants who had type 2 diabetes. Although both type 1 and type 2 diabetes 
relate to blood sugar control, an individual with type 1 diabetes may have more violate variations 
of blood glucose excursions and studies are needed to identify whether this would lead to an 
increased rate of postoperative complications in and of itself. In addition, someone with type 1 
diabetes would most likely have had diabetes for numerous years when we compare type 1 and 
type 2 diabetes related to the usual younger onset of type 1 diabetes. 
 Comparing the above case report with the literature review analysis presented, one can 
easily become confused as to what an ideal preoperative glycated hemoglobin value should be.  
We know that the patient has type 2 diabetes mellitus. She is on Metformin, and Rybelsus for her 
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diabetes control. Her glucose was reported as 98 mg/dl on her CMP panel and her HbA1c was 
reported as 6.2% which would indicate that she has controlled type 2 diabetes mellitus. 
Theoretically, the patient in the case report would have a reduced risk of postoperative 
complications than someone who has a HbA1c of 10.0%. Therefore, it would be reasonable for 
this patient to go ahead with her scheduled right knee arthroplasty and one would anticipate a 
lower risk for postoperative complications.  
 However, if this patient presented for her preoperative clearance and everything was the 
same except her glycated hemoglobin came back at 12.0%, it is unclear where to go from there. 
From the literature review, one could conclude that this patient might be better off having the 
surgery cancelled and gaining better control of blood sugars prior to surgery to avoid 
postoperative complications. Although the studies agree that controlled glucose preoperative is 
desired, they do not give any direction as to how long someone should have controlled blood 
sugars preoperatively or a consensus on when to postpone surgery.  
 In a review of the literature it has been identified that more research is needed to help 
guide providers in selecting a specific preoperative glycated hemoglobin level to reduce patient 
risk. There is large variation between the studies themselves, much less any consensus on a 
specific glycated hemoglobin value. The one consensus supported throughout the studies reveal 
that the higher the preoperative glycated hemoglobin value the greater the risk of postoperative 
complications (Biancari et al., 2017; Blankush et al., 2016; Cancienne, Cooper et al., 2017; 
Cancienne, Werner et al., 2017; Dhatariya et al., 2016; Goodenough et al., 2015; Haines et al., 
2018; Hwang et al., 2015; Nicolini et al., 2018; Pinxia Chen et al., 2018; Rollins et al., 2016; 
Shohat et al., 2018). 
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 Until a specific guideline is created the determination for surgery will continue to be up 
to the surgeon…...potentially putting patients at greater risk for postoperative complications. 
Learning Points 
• Literature supports that preoperative glucose control is a reliable indicator of 
postoperative complication risk. 
• There is no consensus on a specific preoperative glycated hemoglobin number to 
be obtained prior to surgery. Know your institutions guidelines. 
• Evidence is consistent in finding that a reduction in the preoperative glycated 
hemoglobin correlates directly with the reduction of postoperative complications. 
• More studies are needed to come to a consensus on what constitutes adequate 
glucose control preoperatively as measured by the glycated hemoglobin. 
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